Direct Vasodilators and Sympatholytic Agents

    June 2015 in “ Journal of cardiovascular pharmacology and therapeutics ”
    Meghan N. McComb, James Y. Chao, Tien M. H. Ng
    Studysummary This article discusses the use of direct vasodilators and sympatholytic agents in hypertension management, highlighting their utility in specific cases like refractory hypertension and heart failure, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.sagepub.com →
    Discuss this study in the Community →

    Research cited in this study 11

    1. Minoxidil: An Underused Vasodilator for Resistant or Severe Hypertension Journal of Clinical Hypertension · 2004
    2. Electrophysiological Mechanisms of Minoxidil Sulfate-Induced Vasodilation of Rabbit Portal Vein Circulation Research · 1989
    3. A Comparison of Minoxidil and Hydralazine in Non-Azotemic Hypertensives Journal of Hypertension · 1983
    4. Minoxidil: A Review of Its Pharmacological Properties and Therapeutic Use Drugs · 1981
    5. Minoxidil Southern Medical Journal · 1980
    6. Minoxidil Treatment of Malignant Hypertension JAMA · 1978
    7. Long-Term Clinical Effects, Bioavailability, and Kinetics of Minoxidil in Relation to Renal Function The Journal of Clinical Pharmacology · 1978
    8. Minoxidil in Resistant Hypertension The Lancet · 1977
    9. Minoxidil for Severe Hypertension After Failure of Other Hypotensive Drugs BMJ · 1977
    10. Effect of Minoxidil on Blood Pressure and Hemodynamics in Severe Hypertension American Journal of Cardiology · 1977
    11. Minoxidil in Severe Hypertension: Value When Conventional Drugs Have Failed American Heart Journal · 1975